Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: a multicenter, randomized, clinical intervention trial.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 17848609)

Published in Diabetes Care on September 11, 2007

Authors

Iris Shai1, Julio Wainstein, Ilana Harman-Boehm, Itamar Raz, Drora Fraser, Assaf Rudich, Meir J Stampfer

Author Affiliations

1: S. Daniel Abraham International Center for Health and Nutrition, Department of Epidemiology and Health Systems Evaluation, Ben-Gurion University of the Negev, P.O. Box 653, Beer-Sheva 84105, Israel. irish@bgu.ac.il

Associated clinical trials:

Moderate Alcohol Intake Among Patients With Type 2 Diabetes | NCT00295334

Articles citing this

Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85

Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72

Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc (2009) 2.33

Joint association of glycemic load and alcohol intake with type 2 diabetes incidence in women. Am J Clin Nutr (2011) 1.63

Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr (2010) 1.55

The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med (2008) 1.21

Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation (2009) 1.18

Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia (2008) 1.18

Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr (2010) 1.12

Changes in alcohol consumption and subsequent risk of type 2 diabetes in men. Diabetes (2010) 0.98

Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. EPMA J (2013) 0.94

Alcohol consumption and diabetes risk in the Diabetes Prevention Program. Am J Clin Nutr (2009) 0.89

Moderate alcohol use and cardiovascular disease from Mendelian randomization. PLoS One (2013) 0.89

Alcohol use of diabetes patients: the need for assessment and intervention. Acta Diabetol (2010) 0.84

Effects of Chinese liquors on cardiovascular disease risk factors in healthy young humans. ScientificWorldJournal (2012) 0.78

Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: Women's Health Initiative Observational Study. Eur J Nutr (2009) 0.77

Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development. Eur J Nutr (2015) 0.77

At-risk drinking among diabetic patients. Subst Abuse (2009) 0.76

Moderate Alcohol Consumption and Chronic Disease: The Case for a Long-Term Trial. Alcohol Clin Exp Res (2016) 0.75

Differential Effect of Initiating Moderate Red Wine Consumption on 24-h Blood Pressure by Alcohol Dehydrogenase Genotypes: Randomized Trial in Type 2 Diabetes. Am J Hypertens (2015) 0.75

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J (2007) 9.80

A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34

Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med (2005) 5.27

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol (2014) 4.67

Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66

Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med (2011) 4.61

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21

Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19

Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96

Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94

Diet and lifestyle risk factors associated with incident hypertension in women. JAMA (2009) 3.94

Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation (2005) 3.85

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81

Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med (2015) 3.78

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer (2007) 3.77

Smoking and smoking cessation in relation to mortality in women. JAMA (2008) 3.68

Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA (2002) 3.68

Major dietary protein sources and risk of coronary heart disease in women. Circulation (2010) 3.65

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55

Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst (2003) 3.54

Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45

Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med (2004) 3.42

Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39

A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32

Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17

Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08

Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst (2002) 3.03

Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr (2002) 3.00

Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96

Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis (2002) 2.95

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94

Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86

Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst (2011) 2.85

Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab (2007) 2.81

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation (2002) 2.78

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77

A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov (2011) 2.77

Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol (2002) 2.75

Mercury and the risk of coronary heart disease in men. N Engl J Med (2002) 2.71

Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol (2005) 2.70

A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med (2005) 2.66

Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design. J Diabetes Complications (2005) 2.64

Smoking and prostate cancer survival and recurrence. JAMA (2011) 2.63

Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol (2004) 2.60

Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med (2004) 2.56

Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res (2009) 2.54

Long-term aspirin use and mortality in women. Arch Intern Med (2007) 2.54

Prospective study of major dietary patterns and stroke risk in women. Stroke (2004) 2.52

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50

A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst (2002) 2.49

Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet (2011) 2.48

Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med (2003) 2.47

Development of a semi-quantitative Food Frequency Questionnaire (FFQ) to assess dietary intake of multiethnic populations. Eur J Epidemiol (2003) 2.46

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45

Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum (2007) 2.44

Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol (2011) 2.42

Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab (2002) 2.40

Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest (2009) 2.39

Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation (2006) 2.35

Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA (2011) 2.34

Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res (2008) 2.33

Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation (2005) 2.29

Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum (2009) 2.26

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol (2005) 2.25

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care (2006) 2.25

Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care (2004) 2.24